Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to 0.27%.

  • Niagen Bioscience's Return on Capital Employed rose 2600.0% to 0.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27%, marking a year-over-year increase of 2600.0%. This contributed to the annual value of 0.18% for FY2024, which is 3400.0% up from last year.
  • According to the latest figures from Q3 2025, Niagen Bioscience's Return on Capital Employed is 0.27%, which was up 2600.0% from 0.26% recorded in Q2 2025.
  • Over the past 5 years, Niagen Bioscience's Return on Capital Employed peaked at 0.27% during Q3 2025, and registered a low of 0.88% during Q2 2022.
  • In the last 5 years, Niagen Bioscience's Return on Capital Employed had a median value of 0.2% in 2023 and averaged 0.26%.
  • Per our database at Business Quant, Niagen Bioscience's Return on Capital Employed plummeted by -1500bps in 2022 and then soared by 6300bps in 2023.
  • Quarter analysis of 5 years shows Niagen Bioscience's Return on Capital Employed stood at 0.65% in 2021, then rose by 11bps to 0.58% in 2022, then soared by 71bps to 0.17% in 2023, then skyrocketed by 204bps to 0.17% in 2024, then soared by 54bps to 0.27% in 2025.
  • Its Return on Capital Employed was 0.27% in Q3 2025, compared to 0.26% in Q2 2025 and 0.25% in Q1 2025.